Fizer Pharmaceutical paid $85 million on January 2, 2021. for 5 million shares of Came Cosmetics common stock. The investment represents a 20% interest in the net assets of Care and gave Fizer the ability to exercise significant influence over Carne's operations. Fizer received dividends of $3 per share on December 21, 2021, and Carne reported net income of $35 million for the year ended December 31, 2021 The fair value of Carne's common stock at December 31, 2021, was $35.50 per share. The book value of Care's net assets was $210 million The fair value of Carne's depreciable assets exceeded their book value by $50 million. These assets had an average remaining useful life of ten years The remainder of the excess of the cost of the investment over the book value of net assets purchased was attributable to goodwill Required: Complete the table below and prepare the appropriate journal entries related to the investment during 2021 No Transaction 1 Credit 1 General Journal Investment in equity affiliate Cash Dobit 85 85 2 2 > 70 Investment in equity affiliate Investment revenue 7 3 3 Cash Investment in equity affiliate 4 4 Cash Investment in equily affiliate 5 5 Fair value adjustment Cash